3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Thoracic
1
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
16
Uterine Cervical Neoplasms
8
Melanoma
7
Colorectal Neoplasms
7
Fallopian Tube Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
5
Breast Neoplasms
5
Recurrence
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Turcot syndrome
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
pembrolizumab
4
Paclitaxel
3
Bevacizumab
3
fludarabine
2
Nivolumab
2
Drug Therapy
2
Cyclophosphamide
2
Azacitidine
2
vocimagene amiretrorepvec
1
ulixertinib
1
spartalizumab
1
sapanisertib
1
sacituzumab govitecan
1
ruxolitinib
1
rucaparib
1
ridaforolimus
1
regorafenib
1
pazopanib
1
motexafin gadolinium
1
lenvatinib
1
epacadostat
1
cobimetinib
1
cediranib
1
cc-486
1
carboxyamido-triazole
1
aflibercept
1
abiraterone
1
Uncertainty
1
Sirolimus
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Interleukin-2
×
Gynecologic
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled